Inhibrx Biosciences (INBX) Interest & Investment Income (2023 - 2026)

Inhibrx Biosciences (INBX) has reported Interest & Investment Income for 3 consecutive years, with $1.3 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Interest & Investment Income fell 34.45% year-over-year to $1.3 million; the TTM figure through Dec 2025 stood at $7.5 million (down 31.0% YoY), while the FY2025 annual figure was $7.5 million, down 31.0% from the prior year.
• Interest & Investment Income slipped to $1.3 million in Q4 2025 per INBX's latest filing, from $1.8 million in the prior quarter.
• Across five years, Interest & Investment Income topped out at $4.7 million in Q4 2023 and bottomed at $1.3 million in Q4 2025.
• Historically, Interest & Investment Income has averaged $2.5 million across 3 years, with a median of $2.3 million in 2025.
• On a YoY basis, Interest & Investment Income climbed as much as 24.44% in 2024 and fell as far as 57.35% in 2024.
• Inhibrx Biosciences' Interest & Investment Income stood at $4.7 million in 2023, then slumped by 57.35% to $2.0 million in 2024, then tumbled by 34.45% to $1.3 million in 2025.
• Business Quant data shows INBX's Interest & Investment Income at $1.3 million in Q4 2025, $1.8 million in Q3 2025, and $2.1 million in Q2 2025.